Malaria Molecular Epidemiology: Lessons from the International Centers of Excellence for Malaria Research Network
Genre
Journal ArticleDate
2015-09-01Author
Escalante, AAFerreira, MU
Vinetz, JM
Volkman, SK
Cui, L
Gamboa, D
Krogstad, DJ
Barry, AE
Carlton, JM
van Eijk, AMA
Pradhan, K
Mueller, I
Greenhouse, B
Pacheco, MA
Vallejo, AF
Herrera, S
Felger, I
Subject
Gene FlowGenetics, Population
Genotyping Techniques
Humans
International Cooperation
Malaria
Malaria, Falciparum
Malaria, Vivax
Molecular Epidemiology
Plasmodium
Plasmodium falciparum
Plasmodium vivax
Permanent link to this record
http://hdl.handle.net/20.500.12613/5206
Metadata
Show full item recordDOI
10.4269/ajtmh.15-0005Abstract
© The American Society of Tropical Medicine and Hygiene. Molecular epidemiology leverages genetic information to study the risk factors that affect the frequency and distribution of malaria cases. This article describes molecular epidemiologic investigations currently being carried out by the International Centers of Excellence for Malaria Research (ICEMR) network in a variety of malaria-endemic settings. First, we discuss various novel approaches to understand malaria incidence and gametocytemia, focusing on Plasmodium falciparum and Plasmodium vivax. Second, we describe and compare different parasite genotyping methods commonly used in malaria epidemiology and population genetics. Finally, we discuss potential applications of molecular epidemiological tools and methods toward malaria control and elimination efforts.Citation to related work
American Society of Tropical Medicine and HygieneHas part
The American journal of tropical medicine and hygieneADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.eduae974a485f413a2113503eed53cd6c53
http://dx.doi.org/10.34944/dspace/5188
Scopus Count
Collections
Related items
Showing items related by title, author, creator and subject.
-
Plasmodium falciparum K76T pfcrt gene mutations and parasite population structure, Haiti, 2006–2009Charles, M; Das, S; Daniels, R; Kirkman, L; Delva, GG; Destine, R; Escalante, A; Villegas, L; Daniels, NM; Shigyo, K; Volkman, SK; Pape, JW; Golightly, LM (2016-05-01)© 2016, Centers for Disease Control and Prevention (CDC). All rights reserved. Hispaniola is the only Caribbean island to which Plasmodium falciparum malaria remains endemic. Resistance to the antimalarial drug chloroquine has rarely been reported in Haiti, which is located on Hispaniola, but the K76T pfcrt (P. falciparum chloroquine resistance transporter) gene mutation that confers chloroquine resistance has been detected intermittently. We analyzed 901 patient samples collected during 2006–2009 and found 2 samples showed possible mixed parasite infections of genetically chloroquine-resistant and -sensitive parasites. Direct sequencing of the pfcrt resistance locus and single-nucleotide polymorphism barcoding did not definitively identify a resistant population, suggesting that sustained propagation of chloroquine-resistant parasites was not occurring in Haiti during the study period. Comparison of parasites from Haiti with those from Colombia, Panama, and Venezuela reveals a geographically distinct population with highly related parasites. Our findings indicate low genetic diversity in the parasite population and low levels of chloroquine resistance in Haiti, raising the possibility that reported cases may be of exogenous origin.
-
Phylogeographic evidence for 2 genetically distinct zoonotic Plasmodium knowlesi Parasites, MalaysiaYusof, R; Ahmed, MA; Jelip, J; Ngian, HU; Mustakim, S; Hussin, HM; Fong, MY; Mahmud, R; Sitam, FAT; Rovie-Ryan Japning, J; Snounou, G; Escalante, AA; Lau, YL (2016-08-01)© 2016, Centers for Disease Control and Prevention (CDC). All rights reserved. Infections of humans with the zoonotic simian malaria parasite Plasmodium knowlesi occur throughout Southeast Asia, although most cases have occurred in Malaysia, where P. knowlesi is now the dominant malaria species. This apparently skewed distribution prompted an investigation of the phylogeography of this parasite in 2 geographically separated regions of Malaysia, Peninsular Malaysia and Malaysian Borneo. We investigated samples collected from humans and macaques in these regions. Haplotype network analyses of sequences from 2 P. knowlesi genes, type A small subunit ribosomal 18S RNA and cytochrome c oxidase subunit I, showed 2 genetically distinct divergent clusters, 1 from each of the 2 regions of Malaysia. We propose that these parasites represent 2 distinct P. knowlesi types that independently became zoonotic. These types would have evolved after the sea-level rise at the end of the last ice age, which separated Malaysian Borneo from Peninsular Malaysia.
-
Multiplicity of Infection and Disease Severity in Plasmodium vivaxPacheco, MA; Lopez-Perez, M; Vallejo, AF; Herrera, S; Arévalo-Herrera, M; Escalante, AA (2016-01-11)© 2016 Pacheco et al. Background: Multiplicity of infection (MOI) refers to the average number of distinct parasite genotypes concurrently infecting a patient. Although several studies have reported on MOI and the frequency of multiclonal infections in Plasmodium falciparum, there is limited data on Plasmodium vivax. Here, MOI and the frequency of multiclonal infections were studied in areas from South America where P. vivax and P. falciparum can be compared. Methodology/Principal Findings: As part of a passive surveillance study, 1,328 positive malaria patients were recruited between 2011 and 2013 in low transmission areas from Colombia. Of those, there were only 38 P. vivax and 24 P. falciparum clinically complicated cases scattered throughout the time of the study. Samples from uncomplicated cases were matched in time and location with the complicated cases in order to compare the circulating genotypes for these two categories. A total of 92 P. vivax and 57 P. falciparum uncomplicated cases were randomly subsampled. All samples were genotyped by using neutral microsatellites. Plasmodium vivax showed more multiclonal infections (47.7%) than P. falciparum (14.8%). Population genetics and haplotype network analyses did not detect differences in the circulating genotypes between complicated and uncomplicated cases in each parasite. However, a Fisher exact test yielded a significant association between having multiclonal P. vivax infections and complicated malaria. No association was found for P. falciparum infections. Conclusion: The association between multiclonal infections and disease severity in P. vivax is consistent with previous observations made in rodent malaria. The contrasting pattern between P. vivax and P. falciparum could be explained, at least in part, by the fact that P. vivax infections have lineages that were more distantly related among them than in the case of the P. falciparum multiclonal infections. Future research should address the possible role that acquired immunity and exposure may have on multiclonal infections and their association with disease severity.